Calendar
event
Ex dividend date
14 Nov 2025
calendar_clock
Next Dividend Payment
25 Nov 2025
About Iradimed Co
Ticker
info
IRMD
Trading on
info
NASDAQ
ISIN
info
US46266A1097
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Roger E. Susi
Headquarters
info
1025 Willa Springs Drive, Winter Springs, FL, United States, 32708
Employees
info
160
Website
info
iradimed.com
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Metrics
BasicAdvanced
Market cap
info
$1.09B
P/E ratio
info
52.16
EPS
info
$1.65
Dividend Yield
info
0.81%
Beta
info
1.1
Forward P/E ratio
info
39.84
EBIDTA
info
$25.8M
Ex dividend date
info
2025-11-14
Price & volume
Market cap
info
$1.09B
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.68
Dividend yield
info
0.81%
Forward dividend per share
info
$0.68
Forward dividend yield
info
0.79%
Payout ratio
info
39.31%
Valuation
P/E ratio
info
52.16
Forward P/E
info
39.84
PEG ratio
info
4.46
Trailing P/E
info
52.16
Price to sales
info
13.6
Price to book
info
10.91
Earnings
EPS
info
$1.65
EPS estimate (current quarter)
info
$0.46
EPS estimate (next quarter)
info
$0.47
EBITDA
info
$25.8M
Revenues (TTM)
info
$80.5M
Revenues per share (TTM)
info
$6.34
Technicals
Beta
info
1.1
52-week High
info
$87.88
52-week Low
info
$47.21
50-day moving average
info
$74.36
200-day moving average
info
$61.87
Short ratio
info
2.81
Short %
info
1.99%
Management effectiveness
ROE (TTM)
info
23.31%
ROA (TTM)
info
14.87%
Profit margin
info
26.31%
Gross profit margin
info
$62.1M
Operating margin
info
32.23%
Growth
Quarterly earnings growth (YoY)
info
7.90%
Quarterly revenue growth (YoY)
info
15.70%
Share stats
Outstanding Shares
info
12.7M
Float
info
7.2M
Insiders %
info
36.82%
Institutions %
info
57.46%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$86.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.40
$0.41
-2.44%
Q4 • 24Missed
$0.37
$0.38
-2.63%
Q1 • 25Missed
$0.49
$0.44
11.36%
Q2 • 25Beat
$0.47
$0.46
2.17%
Q3 • 25Beat
-
-
-
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$20.4M
$5.8M
28.29%
Q2 • 25
$21.2M
$5.6M
26.30%
Q3 • 25
3.88%
-3.42%
-7.03%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$106M
$12.1M
11.41%
Q2 • 25
$115M
$16.4M
14.27%
Q3 • 25
7.77%
34.77%
25.05%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$7.7M
$-2.8M
$-2.3M
$4.9M
Q2 • 25
$7M
$-1.3M
$-2.2M
$5.8M
Q3 • 25
-9.81%
-55.25%
-2.90%
18.81%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Iradimed Co share?
Collapse

Iradimed Co shares are currently traded for undefined per share.

How many shares does Iradimed Co have?
Collapse

Iradimed Co currently has 12.7M shares.

Does Iradimed Co pay dividends?
Collapse

Yes, Iradimed Co does pay dividends.

What is Iradimed Co 52 week high?
Collapse

Iradimed Co 52 week high is $87.88.

What is Iradimed Co 52 week low?
Collapse

Iradimed Co 52 week low is $47.21.

What is the 200-day moving average of Iradimed Co?
Collapse

Iradimed Co 200-day moving average is $61.87.

Who is Iradimed Co CEO?
Collapse

The CEO of Iradimed Co is Roger E. Susi.

How many employees Iradimed Co has?
Collapse

Iradimed Co has 160 employees.

What is the market cap of Iradimed Co?
Collapse

The market cap of Iradimed Co is $1.09B.

What is the P/E of Iradimed Co?
Collapse

The current P/E of Iradimed Co is 52.16.

What is the EPS of Iradimed Co?
Collapse

The EPS of Iradimed Co is $1.65.

What is the PEG Ratio of Iradimed Co?
Collapse

The PEG Ratio of Iradimed Co is 4.46.

What do analysts say about Iradimed Co?
Collapse

According to the analysts Iradimed Co is considered a buy.